{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"54","upperLimit":"62","value":"58"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"448"}],"units":"Participants"}],"description":"Compliance rates are calculated to monitor the compliance with long-term quality of life and functional status data submission. A patient will be compliant if the patient has metacognition index score. Compliance rates will be assessed at each of the 3 neurocognitive/quality of life assessment time windows. All eligible and evaluable patients enrolled will be used. Patients removed from treatment prior to the time of neuropsychological assessment (for reasons such as disease progression, death, withdrawal of consent, etc.) will not be included in the denominator to assess the compliance rate. The time window is 4 - 15 months post diagnosis.","dispersionType":"95% Confidence Interval","groups":[{"description":"All eligible and evaluable patients enrolled on ACNS0331","id":"OG000","title":"Eligible and Evaluable Patients"}],"paramType":"NUMBER","populationDescription":"All eligible and evaluable patients enrolled. Patients removed from treatment prior to the time of neuropsychological assessment (for reasons such as disease progression, death, withdrawal of consent, etc.) will not be included in the denominator to assess the compliance rate.","reportingStatus":"POSTED","timeFrame":"4-15 months post diagnosis","title":"Compliance Rates for All Eligible and Evaluable Patients Enrolled Within Time Window 1 (4-15 Months Post Diagnosis)","type":"SECONDARY","unitOfMeasure":"Percentage of Participants"}